Antibiotic Treatment for Acute Bacterial Sinusitis in Adults

First-Line Antibiotic Choice

Amoxicillin-clavulanate 875 mg/125 mg twice daily for 5-10 days is the preferred first-line antibiotic for most adults with acute bacterial sinusitis. 1, 2

The American Academy of Otolaryngology-Head and Neck Surgery establishes amoxicillin with or without clavulanate as first-line therapy, but amoxicillin-clavulanate is preferred over plain amoxicillin due to increasing prevalence of β-lactamase-producing organisms (Haemophilus influenzae and Moraxella catarrhalis). 1, 3 This combination provides 90-92% predicted clinical efficacy against the major pathogens. 1, 3

When to Use Plain Amoxicillin Instead

Plain amoxicillin 500 mg twice daily (mild disease) or 875 mg twice daily (moderate disease) is acceptable only for uncomplicated cases without recent antibiotic exposure within the past 4-6 weeks. 1, 3, 2 However, given the high prevalence of resistant organisms, amoxicillin-clavulanate remains the safer initial choice. 1, 3

When to Use High-Dose Amoxicillin-Clavulanate

High-dose amoxicillin-clavulanate (2 g amoxicillin/125 mg clavulanate twice daily) should be prescribed for patients with: 1, 3, 2

Recent antibiotic use within the past month
Age >65 years
Moderate-to-severe symptoms or protracted symptoms
Comorbid conditions (diabetes, chronic cardiac/hepatic/renal disease)
Immunocompromised state
High local prevalence of penicillin-resistant S. pneumoniae (>10%)
Close contact with daycare children
Smoking or household smoker

Important caveat: Recent high-quality evidence from 2021 found that high-dose amoxicillin-clavulanate did NOT provide superior efficacy compared to standard-dose (44.3% vs 36.4% improvement at day 3, P=0.35), though this study was stopped early for futility. 4 A 2018 study showed conflicting results depending on formulation used. 5 Given this equipoise and the established guideline recommendations, standard-dose amoxicillin-clavulanate remains appropriate for most patients unless specific risk factors are present. 1, 3

Treatment Duration

Treat for 5-7 days for uncomplicated cases, which is as effective as 10 days with fewer adverse effects. 1, 2, 6

Systematic reviews demonstrate no difference in clinical success between 3-7 day courses versus 6-10 day courses. 1 However, most guidelines still recommend treatment until symptom-free for 7 days, typically resulting in 10-14 days total. 1, 3 For severe infection, immunocompromised patients, or frontal/sphenoidal sinusitis, maintain the standard 10-day duration. 2

Penicillin-Allergic Patients

For Non-Type I (Non-Anaphylactic) Allergy

Second- or third-generation cephalosporins are the preferred alternatives for patients with non-severe penicillin allergy. 1, 3

Options include: 1, 3, 2

Cefuroxime-axetil (second-generation)
Cefpodoxime-proxetil (third-generation, superior activity against H. influenzae)
Cefdinir (third-generation)

The risk of cross-reactivity between penicillins and second/third-generation cephalosporins is negligible (<1%). 3

For Type I (Anaphylactic) Allergy or Severe β-Lactam Allergy

Respiratory fluoroquinolones are the preferred choice for patients with documented severe penicillin allergy. 1, 3, 2

Options include: 1, 3, 2

Levofloxacin 500 mg once daily for 10 days (or 750 mg once daily for 5 days per FDA labeling) 7
Moxifloxacin 400 mg once daily for 10 days

These provide 90-92% predicted clinical efficacy with excellent coverage against drug-resistant S. pneumoniae and β-lactamase-producing organisms. 1, 3

Doxycycline 100 mg once daily for 10 days is an alternative but has lower efficacy (77-81% predicted clinical success) and limited activity against H. influenzae, resulting in a 20-25% bacteriologic failure rate. 1, 3, 2

What NOT to Use

Avoid these antibiotics as first-line therapy: 1, 3

Azithromycin and macrolides: 20-40% resistance rates for S. pneumoniae and H. influenzae 1, 3
Trimethoprim-sulfamethoxazole: 50% resistance for S. pneumoniae, 27% for H. influenzae 1, 3
First-generation cephalosporins (cephalexin): Inadequate coverage against H. influenzae (50% β-lactamase producing) 3
Clindamycin monotherapy: No activity against H. influenzae or M. catarrhalis 3

Confirming the Diagnosis Before Prescribing

Only prescribe antibiotics when acute bacterial rhinosinusitis (ABRS) is confirmed by one of three clinical patterns: 1, 6

Persistent symptoms ≥10 days without clinical improvement
Severe symptoms for ≥3-4 consecutive days: fever ≥39°C (102°F) with purulent nasal discharge and facial pain/pressure
"Double sickening": worsening symptoms after initial improvement from a viral upper respiratory infection

Most acute rhinosinusitis (98-99.5%) is viral and resolves spontaneously within 7-10 days without antibiotics. 1, 3, 6 Do NOT prescribe antibiotics for symptoms <10 days unless severe features are present. 1, 3

Watchful Waiting Option

Watchful waiting without immediate antibiotics is an appropriate initial strategy for uncomplicated ABRS when reliable follow-up can be assured. 1, 2, 6

Start antibiotics only if: 1, 6

No improvement by 7 days after diagnosis
Symptoms worsen at any time

During watchful waiting, provide symptomatic treatment with analgesics, intranasal corticosteroids, and saline nasal irrigation. 1, 6 The number needed to treat with antibiotics is 10-15 to get one additional person better after 7-15 days. 1, 3

Treatment Failure Protocol

Reassess at 3-5 days: If no improvement or worsening, switch antibiotics immediately. 1, 3, 2

Second-Line Options After Amoxicillin-Clavulanate Failure:

Respiratory fluoroquinolone (levofloxacin 500 mg daily or moxifloxacin 400 mg daily for 10 days) 1, 3, 2
High-dose amoxicillin-clavulanate (if not already used) 1, 3
Ceftriaxone 1-2 g IM/IV once daily for 5 days (for patients unable to tolerate oral medications or severe disease) 3, 2

At 7 days: If symptoms persist, reconfirm diagnosis, exclude complications, and consider: 1, 3, 2

CT imaging (only if complications suspected)
Referral to otolaryngology
Sinus aspiration for culture in immunocompromised patients

Essential Adjunctive Therapies

Add these to antibiotic therapy to improve outcomes: 1, 3

Intranasal corticosteroids (mometasone, fluticasone, or budesonide twice daily): Reduce mucosal inflammation and improve symptom resolution 1, 3
Saline nasal irrigation: Provides symptomatic relief and removes mucus 1, 3
Analgesics (acetaminophen or ibuprofen): For pain and fever 1, 3
Decongestants: Limit topical use to 3 days to avoid rebound congestion 1, 3

Short-term oral corticosteroids (5 days) may be considered for patients with marked mucosal edema or failure to respond to initial treatment. 1, 3

Critical Pitfalls to Avoid

Do NOT use fluoroquinolones as first-line therapy in patients without documented β-lactam allergies—reserve them for treatment failures or severe allergies to prevent resistance development. 1, 3, 2
Do NOT prescribe antibiotics for symptoms <10 days unless severe symptoms are present (fever ≥39°C with purulent discharge for ≥3 consecutive days). 1, 3, 6
Do NOT obtain imaging (X-ray or CT) for uncomplicated acute rhinosinusitis unless complications or alternative diagnosis suspected. 1
Do NOT continue ineffective therapy beyond 3-5 days—early reassessment is critical to catch treatment failures. 1, 3, 2
Ensure adequate treatment duration (minimum 5 days for adults, 10 days for children) to prevent relapse. 1, 3

Expected Timeline for Improvement

Most patients should experience noticeable improvement within 3-5 days of starting appropriate antibiotic therapy. 1, 3 By day 7, approximately 73-85% show clinical improvement. 3 Complete resolution typically occurs by 10-14 days or when symptom-free for 7 consecutive days. 1, 3

If no improvement by 3-5 days, this constitutes treatment failure and requires switching antibiotics. 1, 3, 2 If worsening at any time, immediately reassess for complications (orbital cellulitis, meningitis, brain abscess). 1, 3

What is the recommended antibiotic regimen for an adult patient with acute bacterial sinusitis?

Help us tailor your experience